Qube Research & Technologies LTD Applied Therapeutics Inc. Transaction History
Qube Research & Technologies LTD
- $61.9 Billion
- Q1 2024
A detailed history of Qube Research & Technologies LTD transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 459,141 shares of APLT stock, worth $2.07 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
459,141
Previous 193,673
137.07%
Holding current value
$2.07 Million
Previous $648,000
381.79%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding APLT
# of Institutions
100Shares Held
94MCall Options Held
5.83MPut Options Held
231K-
Franklin Resources Inc San Mateo, CA10.6MShares$47.6 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY9.08MShares$40.9 Million5.3% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$36.1 Million1.14% of portfolio
-
Janus Henderson Group PLC London, X06.41MShares$28.9 Million0.02% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA6.11MShares$27.6 Million24.19% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $217M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...